The Board of Mando Group AB
|
|
|
Margareta Nordenvall,
Board Chairman
Margareta Nordenvall is a physician and a specialist in gynaecology and has worked for many years in public and private health care. During the years 1997-2000, Margareta Nordenvall was president of Sophiahemmet Hospital. Previously she was a member of the Stockholm City Council and was also a Member of Parliament from 1991-97. She now works part-time as a physician and with board assignments within the private health care sector.
|
| |
|
|
|
 |
|
|
Cecilia Bergh,
Board Member and CEO Mando Group AB
Cecilia Bergh, PhD, one of AB Mando’s founders. She has built up the company together with Per Södersten following many years of research concerning eating behaviour and satiety at the Karolinska Institute. |
| |
|
|
|
 |
|
|
Gösta Jonsson,
Board Member
Gösta Jonsson has many years’ experience of R&D in neurology and psychiatry, from both academia (the Karolinska Institute), as well as in pharmaceutical research (Astra/Zeneca). He was president 1989-99 of CNS the at Astra Arcus AB. Gösta Jonsson is a board member of several research companies and an expert at the Life Science programme financed by the Strategic Funds’ Foundation. |
| |
|
|
|
 |
|
|
Karl Swartling,
Board Member
Karl Swartling is Managing Director and Co-Head of Investor Growth Capital Europe (Stockholm). Karl Swartling also serves on the Board of NeuroNova AB and Affibody Holding AB and is deputy board member in Atlas Antibodies AB, Tobii Technologies AB and Cambio Healthcare Systems AB. Karl spent 15 years with the McKinsey & Company consulting firm with main focus on Life Science. Karl Swartling holds an MBA from the Stockholm School of Economics.
|
| |
|
|
|
 |
|
|
Per Södersten,
Board Member
Per Södersten is one of AB Mando’s founders.
He is a professor, active within the section of applied neuroendocrinology at the Karolinska Institute and at the same time director of R&D at AB Mando and Mandolean AB.
|
| |
|
|
|